Physician profile

Austin J Gaal

Oral & Maxillofacial Surgery · Kirkland, WA

NPI 1366867285

$1,234.16

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Oral & Maxillofacial Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$277.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $294.27 2019-2021
Kls-Martin L.P. $292.75 2021-2023
Nobel Biocare USA $261.09 2020-2022
Straumann USA LLC $195.04 2022
Axogen $145.16 2023 Avance Nerve Graft
3m Company $34.20 2023 Scotchbond Universal Plus, Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative
Ace Surgical Supply Co., INC. $11.65 2020-2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Austin J Gaal

$1,234.16

in general payments reported 2019-2025

Years
2019-2023
Top company
Zimmer Biomet Holdings, INC.

https://glasscript.com/doctor/1370613/austin-j-gaal

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.